Medication strategies in first episode psychosis patients: A survey among psychiatrists.


Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
02 2022
Historique:
revised: 09 02 2021
received: 23 10 2020
accepted: 06 03 2021
pubmed: 24 3 2021
medline: 12 3 2022
entrez: 23 3 2021
Statut: ppublish

Résumé

There is an ongoing debate regarding the optimal timing of discontinuation of antipsychotic drugs for patients with first episode psychosis. Although most guidelines recommend maintenance therapy for at least 1 or 2 years after reaching remission, study results indicate that early discontinuation may be beneficial for at least a subsample of patients. To date, little is known about which medication strategies are applied in patients recovering from a first psychotic episode. In this study, we examined the beliefs and practices of clinicians on medication discontinuation. We performed a survey among 50 experienced Dutch psychiatrists to assess how often specific treatment strategies have been applied in the past 12 months, as well as their knowledge and expectations with respect to medication discontinuation. Psychiatrists estimated that, after remission, they continued medication at the same dose for at least 12 months in 51.2% of cases, continued in a reduced dose in 33.8% of cases and discontinued medication in 9.1% of cases after 4.4 months of remission on average. Although the medication is discontinued in only a relatively small proportion of patients, almost half of all clinicians (45.9%) used this strategy at least once in the past 12 months. There is substantial practice variation in antipsychotic medication strategies after remission from a first psychotic episode. Future research on long-term effects of early medication discontinuation can guide clinicians in making evidence-based decisions when treating first-episode patients.

Identifiants

pubmed: 33754470
doi: 10.1111/eip.13138
pmc: PMC9292219
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-146

Investigateurs

Iris Sommer (I)
Lieuwe de Haan (L)
Wim Veling (W)
Jim van Os (J)
Filip Smit (F)
Marieke Begemann (M)
Sanne Schuite-Koops (S)
Machteld Marcelis (M)
Martijn Kikkert (M)
Nico van Beveren (N)
Nynke Boonstra (N)
Bram-Sieben Rosema (BS)
P Roberto Bakker (PR)
Sinan Gülöksüz (S)
Joran Lokkerbol (J)
Bodyl Brand (B)
Shiral Gangadin (S)
Chris Geraets (C)
Erna Van't Hag (E)
Priscilla Oomen (P)
Alban Voppel (A)
Therese van Amelsvoort (T)
Maarten Bak (M)
Agaath Been (A)
Marinte van den Bosch (M)
Truus van den Brink (T)
Gunnar Faber (G)
Koen Grootens (K)
Martin de Jonge (M)
Henderikus Knegtering (H)
Jörg Kurkamp (J)
Amrita Mahabir (A)
Gerdina Hendrika Maria Pijnenborg (GHM)
Tonnie Staring (T)
Wiek Vaes (W)
Natalie Veen (N)
Selene Veerman (S)
Sybren Wiersma (S)

Informations de copyright

© 2021 The Authors. Early Intervention in Psychiatry published by John Wiley & Sons Australia, Ltd.

Références

Aust N Z J Psychiatry. 2016 May;50(5):410-72
pubmed: 27106681
JAMA Psychiatry. 2013 Sep;70(9):898-900
pubmed: 23824206
World J Biol Psychiatry. 2013 Feb;14(1):2-44
pubmed: 23216388
Schizophr Res. 2018 Jul;197:65-66
pubmed: 29128323
Early Interv Psychiatry. 2022 Feb;16(2):139-146
pubmed: 33754470
Schizophr Bull. 2013 Sep;39(5):962-5
pubmed: 23512950
BMJ Open. 2017 Jan 6;7(1):e013881
pubmed: 28062471
Int J Ment Health Nurs. 2014 Feb;23(1):69-78
pubmed: 23211033
Int J Neuropsychopharmacol. 2014 Jul;17(7):1083-93
pubmed: 22717078
Psychother Psychosom. 2008;77(2):69-77
pubmed: 18230939
Early Interv Psychiatry. 2016 Aug;10(4):355-61
pubmed: 25962446
Schizophr Bull. 2010 Jan;36(1):71-93
pubmed: 19955390
Trials. 2020 Feb 07;21(1):147
pubmed: 32033579
Trials. 2017 Sep 29;18(1):445
pubmed: 28962668
Psychiatr Clin North Am. 2012 Sep;35(3):661-81
pubmed: 22929872
Prim Care Companion CNS Disord. 2017 Dec 7;19(6):
pubmed: 29216418
Neuropsychiatr Dis Treat. 2016 Jan 06;12:57-67
pubmed: 26792993
Cochrane Database Syst Rev. 2012 May 16;(5):CD008016
pubmed: 22592725
Early Interv Psychiatry. 2019 Dec;13(6):1345-1356
pubmed: 30488637
Schizophr Bull. 2005 Jul;31(3):705-22
pubmed: 16006592
Int Rev Psychiatry. 2019 Aug - Sep;31(5-6):441-459
pubmed: 31225767
BMJ Open. 2019 Nov 27;9(11):e030912
pubmed: 31780589
Lancet Psychiatry. 2018 May;5(5):432-442
pubmed: 29551618
CNS Drugs. 2013 Jul;27(7):545-72
pubmed: 23821039
Am J Psychiatry. 2004 Feb;161(2 Suppl):1-56
pubmed: 15000267
Eur Psychiatry. 2006 Jan;21(1):29-33
pubmed: 16460918
Pharmacopsychiatry. 2003 Jul;36(4):143-9
pubmed: 12905100
BMC Psychiatry. 2014 Nov 30;14:341
pubmed: 25433495
J Psychopharmacol. 2011 May;25(5):567-620
pubmed: 21292923
Eur Psychiatry. 2002 May;17(3):148-54
pubmed: 12052575
Am J Psychiatry. 2018 Aug 1;175(8):765-773
pubmed: 29621900
JAMA Psychiatry. 2013 Sep;70(9):913-20
pubmed: 23824214
Eur Neuropsychopharmacol. 2014 Apr;24(4):499-509
pubmed: 24491953
Med Hypotheses. 2006;67(3):517-23
pubmed: 16632226

Auteurs

Martijn J Kikkert (MJ)

Department of Research, Arkin Mental Health Care, Amsterdam, The Netherlands.

Wim Veling (W)

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Lieuwe de Haan (L)

Department of Early Psychosis, Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands.

Marieke J H Begemann (MJH)

Department of Biomedical Sciences of Cells & Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.

Mariken de Koning (M)

Department of Research, Arkin Mental Health Care, Amsterdam, The Netherlands.

Iris E Sommer (IE)

Department of Biomedical Sciences of Cells & Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH